With a history spanning more than 350 years, Merck, the world’s oldest pharmaceutical company, is steadfastly advancing toward becoming a global leader in healthcare. In the healthcare sector, Merck has built a remarkably stable portfolio, including oncology, neurology, immunology, endocrinology, an
Novo Nordisk, the global healthcare company focusing on diabetes care, has been a significant part of Korea's healthcare landscape for several years.The company has established a robust presence in Korea, contributing to its healthcare advancements, particularly in diabetes and obesity. It has also
AstraZeneca is renowned for its blockbuster oncology drugs. However, the Covid-19 pandemic has recently shifted the company's focus to its infectious disease portfolio, including its Covid-19 vaccine, Vaxzevria, and treatment, Evusheld.During the recent Global Vaccine and Immunization Research Forum
Korea has a very complicated drug pricing policy and the government should allow pharmaceutical companies to access review data for reimbursement, Eli Lilly Korea’s leader said.Eli Lilly, a multinational pharmaceutical company approaching its 150th anniversary, appointed Christopher J. Stokes to lea
After becoming the general manager of Merck Biopharma Korea in 2019, Javed Alam has worked to transform the company into a specialty care leader by responding to unmet needs in the area of rare diseases.Industry insiders say that despite the huge obstacle of the Covid-19 pandemic, Alam played a cent
Bayer AG is a familiar name to Koreans – and foreigners as well.The Germany-based multinational pharmaceutical company is the developer of aspirin, a medication used to reduce pain, fever, or inflammation.Aspirin is one of the most widely used medications globally, with an estimated 40,000 tons cons
It was in October 2018 that Nic Horridge took office as head of Roche Korea. Since then, he has been working to change the corporate culture of the multinational pharma’s Korean offshoot and deliver the company's medicines to patients better.This year, his endeavor has run into a significant obstacl
Korea's medical and pharmaceutical industries have reached a global level over the past years. Such exponential growth has made the country one of the major players in the world participating in global researches jointly with multinational companies. Against this backdrop, Korea Biomedical Review ha
Like most multinational pharmaceuticals here, Novo Nordisk Korea has concerns over the country’s volatile drug pricing policies and the possibility of it affecting the company’s efforts to provide better treatments to patients, its CEO says.“Although the company has been thriving recently due to Kor
Korea's medical and pharmaceutical industries have reached a global level over the past years. Such exponential growth has made the country one of the major players in the world participating in global researches with other multinational companies. Against this backdrop, Korea Biomedical Review has
